Exits

Name Description Eventsort icon Date Acquired By
<a href="http://www.aveopharma.com" target="_blank">AVEO Pharmaceuticals, Inc.</a> Discovering, developing and commercializing cancer therapeutics. IPO 2010
<a href="http://www.bg-medicine.com/" target="_blank">BG Medicine, Inc.</a> Developing and delivering diagnostic solutions to aid in the clinical management of heart failure and related disorders. IPO 2011
<a href="http://www.agios.com/" target="_blank">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs to treat cancer and inborn errors of metabolism. IPO 2013
<a href="http://www.combinatorx.com" target="_blank">Zalicus</a> Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. IPO 2005
<a href="http://www.concertpharma.com" target="_blank">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. IPO 2014
<a href="http://www.acceleronpharma.com/" target="_blank">Acceleron Pharma, Inc.</a> Discovering, developing and commercializing novel protein therapeutics for cancer and rare diseases. IPO 2013
<a href="http://www.bindtherapeutics.com/" target="_blank">BIND Therapeutics, Inc.</a> Nanomedicine platform company developing Accurins, its novel targeted therapeutics. IPO 2013
<a href="http://www.elevenbio.com/" target="_blank">Eleven Biotherapeutics, Inc.</a> Discovering and developing protein therapeutics to treat diseases of the eye. IPO 2014
<a href="http://www.receptos.com/" target="_blank">Receptos, Inc.</a> Developing therapeutic candidates for the treatment of immune and metabolic diseases. IPO 2013
<a href="http://tphase.com/home" target="_blank">Tetraphase Pharmaceuticals, Inc.</a> Creating novel antibiotics for serious and life-threatening multidrug-resistant (MDR) bacterial infections. IPO 2013
<a href="http://www.adolor.com/" target="_blank">Adolor Corporation</a> Discovery, development and commercialization of prescription pain management products IPO 2000
<a href="http://www.insmed.com" target="_blank">INSMED, Incorporated</a> Pharmaceuticals for treatment of metabolic diseases and endocrine disorders IPO 2000
<a href="http://www.idexx.com" target="_blank">IDEXX Laboratories</a> Products that enhance the ability of veterinarians to economically provide advanced medical care IPO 1991
<a href="http://www.hologic.com" target="_blank">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health IPO 1996
<a href="http://www.antigenics.com" target="_blank">Antigenics</a> Technology and products to treat cancers, infectious diseases, and autoimmune disorders IPO 2000
<a href="http://www.celera.com" target="_blank">Celera</a> Sequenced human genome; now focused on therapeutics for cancer and other diseases IPO 2000
<a href="http://www.exactsciences.com/" target="_blank">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers IPO 2001
<a href="/www.evotec.com" target="_blank">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders IPO 2004
<a href="http://www.adnexustx.com" target="_blank">Adnexus Therapeutics</a> Developing new class of therapeutic compounds. Acquired 2007 <a href="http://www.bms.com" target="_blank">Bristol-Myers Squibb</a>
<a href="http://www.regi.com/" target="_blank">LS9</a> Leading renewable chemical technology developer. Acquired 2014